Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Revenue (2016 - 2025)

Historic Revenue for Anaptysbio (ANAB) over the last 11 years, with Q3 2025 value amounting to $76.3 million.

  • Anaptysbio's Revenue rose 15425.59% to $76.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $151.4 million, marking a year-over-year increase of 16473.45%. This contributed to the annual value of $91.3 million for FY2024, which is 43202.77% up from last year.
  • As of Q3 2025, Anaptysbio's Revenue stood at $76.3 million, which was up 15425.59% from $22.3 million recorded in Q2 2025.
  • Anaptysbio's Revenue's 5-year high stood at $76.3 million during Q3 2025, with a 5-year trough of $970000.0 in Q1 2022.
  • In the last 5 years, Anaptysbio's Revenue had a median value of $9.0 million in 2023 and averaged $14.5 million.
  • In the last 5 years, Anaptysbio's Revenue crashed by 9831.5% in 2021 and then surged by 80467.15% in 2024.
  • Over the past 5 years, Anaptysbio's Revenue (Quarter) stood at $1.0 million in 2021, then surged by 394.56% to $5.0 million in 2022, then surged by 80.1% to $9.0 million in 2023, then skyrocketed by 177.62% to $25.0 million in 2024, then surged by 205.28% to $76.3 million in 2025.
  • Its last three reported values are $76.3 million in Q3 2025, $22.3 million for Q2 2025, and $27.8 million during Q1 2025.